Ozempic and Cancer Risk — Reading Between the Headlines

Impossible d'ajouter des articles

Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.

Veuillez réessayer plus tard

Échec de l’élimination de la liste d'envies.

Veuillez réessayer plus tard

Impossible de suivre le podcast

Impossible de ne plus suivre le podcast

Ozempic and Cancer Risk — Reading Between the Headlines

Écouter gratuitement

Voir les détails

À propos de ce contenu audio

Ben Synth explores the conflicting evidence on GLP-1 drugs and cancer risk, analyzing why a French study showed increased thyroid cancer risk while a 2.5-million-patient international study found none. He examines detection bias, study design, and emerging protective effects against other cancers.

Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

This content was created in partnership and with the help of Artificial Intelligence AI

Aucun commentaire pour le moment